ELDN

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELDN

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2025/03/21	06 : 00	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/03/21	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/03/21	05 : 01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/03/05	06 : 05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/02/15	07 : 34	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/02/15	01 : 22	Edgar (US Regulatory)	Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/02/08	00 : 00	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/30	06 : 05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/14	07 : 30	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2025/01/13	21 : 00	GlobeNewswire Inc.	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/12/20	22 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/23	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/23	07 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/15	06 : 51	Edgar (US Regulatory)	Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/13	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/13	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/13	06 : 01	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/07	06 : 05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/11/06	01 : 44	Edgar (US Regulatory)	Form SC 13G - Statement of Beneficial Ownership by Certain Investors	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/10/30	19 : 36	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/10/30	19 : 24	Edgar (US Regulatory)	Form 424B5 - Prospectus [Rule 424(b)(5)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/10/30	10 : 27	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc